Javle M - Search Results

1

Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer.

Golan T, Sella T, O'Reilly EM, Katz MH, Epelbaum R, Kelsen DP, Borgida A, Maynard H, Kindler H, Friedmen E, Javle M, Gallinger S. Golan T, et al. Among authors: javle m. Br J Cancer. 2017 Mar 14;116(6):697-702. doi: 10.1038/bjc.2017.19. Epub 2017 Feb 9. Br J Cancer. 2017. PMID: 28183138 Free PMC article.

2

Risk factors associated with earlier age of onset in familial pancreatic carcinoma.

James TA, Sheldon DG, Rajput A, Kuvshinoff BW, Javle MM, Nava HR, Smith JL, Gibbs JF. James TA, et al. Among authors: javle mm. Cancer. 2004 Dec 15;101(12):2722-6. doi: 10.1002/cncr.20700. Cancer. 2004. PMID: 15534880 Free article.

3

Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.

Okazaki T, Javle M, Tanaka M, Abbruzzese JL, Li D. Okazaki T, et al. Among authors: javle m. Clin Cancer Res. 2010 Jan 1;16(1):320-9. doi: 10.1158/1078-0432.CCR-09-1555. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028759 Free PMC article.

4

Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma.

Hassan MM, Curley SA, Li D, Kaseb A, Davila M, Abdalla EK, Javle M, Moghazy DM, Lozano RD, Abbruzzese JL, Vauthey JN. Hassan MM, et al. Among authors: javle m. Cancer. 2010 Apr 15;116(8):1938-46. doi: 10.1002/cncr.24982. Cancer. 2010. PMID: 20166205 Free PMC article.

5

Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancer.

Dong X, Javle M, Hess KR, Shroff R, Abbruzzese JL, Li D. Dong X, et al. Among authors: javle m. Gastroenterology. 2010 Aug;139(2):464-73, 473.e1-3. doi: 10.1053/j.gastro.2010.04.042. Epub 2010 Apr 21. Gastroenterology. 2010. PMID: 20416304 Free PMC article.

6

Inhibition of the mammalian target of rapamycin (mTOR) in advanced pancreatic cancer: results of two phase II studies.

Javle MM, Shroff RT, Xiong H, Varadhachary GA, Fogelman D, Reddy SA, Davis D, Zhang Y, Wolff RA, Abbruzzese JL. Javle MM, et al. BMC Cancer. 2010 Jul 14;10:368. doi: 10.1186/1471-2407-10-368. BMC Cancer. 2010. PMID: 20630061 Free PMC article. Clinical Trial.

7

Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer.

Tanaka M, Javle M, Dong X, Eng C, Abbruzzese JL, Li D. Tanaka M, et al. Among authors: javle m. Cancer. 2010 Nov 15;116(22):5325-35. doi: 10.1002/cncr.25282. Cancer. 2010. PMID: 20665488 Free PMC article.

8

Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancer.

Fogelman DR, Wolff RA, Kopetz S, Javle M, Bradley C, Mok I, Cabanillas F, Abbruzzese JL. Fogelman DR, et al. Among authors: javle m. Anticancer Res. 2011 Apr;31(4):1417-20. Anticancer Res. 2011. PMID: 21508395

9

Survival and quality of life of patients with resected pancreatic adenocarcinoma treated with adjuvant interferon-based chemoradiation: a phase II trial.

Katz MH, Wolff R, Crane CH, Varadhachary G, Javle M, Lin E, Evans DB, Lee JE, Fleming JB, Pisters PW. Katz MH, et al. Among authors: javle m. Ann Surg Oncol. 2011 Dec;18(13):3615-22. doi: 10.1245/s10434-011-1847-4. Epub 2011 Jun 24. Ann Surg Oncol. 2011. PMID: 21701927 Clinical Trial.

10

Targeting the insulin growth factor pathway in gastrointestinal cancers.

Golan T, Javle M. Golan T, et al. Among authors: javle m. Oncology (Williston Park). 2011 May;25(6):518-26, 529. Oncology (Williston Park). 2011. PMID: 21717907 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters